CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments
May 23, 2024 08:00 ET
|
CRISPR Therapeutics AG
-Naimish Patel, M.D., appointed to Chief Medical Officer- -Julianne Bruno, M.B.A., promoted to Chief Operating Officer- ZUG, Switzerland and BOSTON, May 23, 2024 (GLOBE NEWSWIRE) --...
Severs Disease Treatment Market Size to Worth USD 1.87 Bn By 2031
May 21, 2024 11:41 ET
|
CMI
Burlingame, May 21, 2024 (GLOBE NEWSWIRE) -- The global Sever's Disease Treatment Market is projected to grow from USD 1.34 billion in 2024, and it is projected to reach USD 1.87 billion by 2031, at...
TransPerfect Announces GlobalLink NEXT Americas 2024 Conference in New York
May 21, 2024 10:00 ET
|
TransPerfect
NEW YORK, May 21, 2024 (GLOBE NEWSWIRE) -- TransPerfect, the world’s largest provider of language and AI solutions for global business, today announced its ninth annual GlobalLink NEXT Americas...
[Latest] Global Non-Small-Cell Lung Cancer Drug Market Size/Share Worth USD 68,888.6 Million by 2033 at a 8.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
May 21, 2024 03:30 ET
|
Custom Market Insights
Austin, TX, USA, May 21, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Non-Small-Cell Lung Cancer Drug Market Size, Trends and Insights By Cancer Type...
Communiqué de presse : Sanofi, Formation Bio et OpenAI annoncent une coopération de première classe autour de l’IA
May 21, 2024 01:30 ET
|
Sanofi - Aventis Groupe
Sanofi, Formation Bio et OpenAI annoncent une coopération de première classe autour de l’IA Paris, New York, New York et San Francisco, Californie, 21 mai 2024. Sanofi, Formation Bio et OpenAI...
Press Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration
May 21, 2024 01:30 ET
|
Sanofi - Aventis Groupe
Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration Paris, New York, N.Y., and San Francisco, CA, May 21, 2024. Sanofi, Formation Bio and OpenAI are collaborating to build...
Idorsia announces changes to Idorsia Executive Committee and Board of Directors
May 21, 2024 01:00 ET
|
Idorsia Pharmaceuticals Ltd
Ad hoc announcement pursuant to Art. 53 LR Jean-Paul Clozel to retire as CEO and stand for election as Chairman of the Board of DirectorsMathieu Simon to stand for re-election to the Board – taking...
Idorsia announces changes to Idorsia Executive Committee and Board of Directors
May 21, 2024 01:00 ET
|
Idorsia Pharmaceuticals Ltd
Ad hoc announcement pursuant to Art. 53 LR Jean-Paul Clozel to retire as CEO and stand for election as Chairman of the Board of DirectorsMathieu Simon to stand for re-election to the Board – taking...
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Avril 2024
May 20, 2024 16:54 ET
|
Sanofi - Aventis Groupe
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés...
Sanofi: Information concerning the total number of voting rights and shares - April 2024
May 20, 2024 16:54 ET
|
Sanofi - Aventis Groupe
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement...